InvestorsHub Logo
Followers 134
Posts 7040
Boards Moderated 0
Alias Born 02/09/2012

Re: FatAlbert1986 post# 379440

Thursday, 10/21/2021 9:11:41 AM

Thursday, October 21, 2021 9:11:41 AM

Post# of 402714
FatAl...don't disagree with most of what you said:

Reformulation would be necessary for the prophylactic use which would take time and money and definitely lead to required trials. Safety and efficacy would have to be reviewed for a new formulation such as an aerosol. I am not the one to guesstimate how long it would take to be used on the population but I do think IPIX will reach further for an aerosol or nasal spray as a broad-spectrum antiviral would be highly coveted.



...except we don't yet know the exact formulation request of and permitted by the FDA during Compassionate Use cases, which, due to the critical condition of the patients, could have been multiples of Clinical Trial dosing during these Compassionate Use cases.

IMO FDA could have learned (and maybe continuing to learn) a lot about the safety and dosage tolerance of Brilacidin during dosing Compassionate Use cases.

IMO...CT and Compassionate Use will likely "blow away" the bogus "safety" issues raised on this board...to the point where a Brilacidin "One-Shot Covid-Killer" dosage could be supported financially and fast-tracked...driven by DOD/CDC/FDA.

We already know through the GMU/RBL tests...that Brilacidin, present upon introduction of Covid-19 ... Destroys the covid virus and its variants...the definition of a prophylactic!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News